Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jul 24, 2023
4 Jul 18, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
3 Jul 18, 2023 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Jul 17, 2023 8-K
8-K Jun 1, 2023 8-K
4 May 18, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 18, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
10-Q May 15, 2023 10-Q
8-K May 15, 2023 8-K
8-K May 12, 2023 8-K
4 May 11, 2023
4 May 11, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 11, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 11, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 11, 2023 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
ARS Apr 11, 2023 ARS
DEF 14A Apr 11, 2023 DEF 14A
8-K Apr 6, 2023 8-K
SC 13D/A Mar 17, 2023
S-8 Mar 14, 2023 S-8
S-8 Mar 14, 2023 S-8
10-K Mar 14, 2023 10-K
8-K Mar 14, 2023 8-K
SC 13G Feb 14, 2023 SC 13G
← Newer Page 7 of 28 · 693 filings Older →